• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超重和肥胖管理的最佳实践。

Best Practices in the Management of Overweight and Obesity.

机构信息

Department of Internal Medicine, Division of Endocrinology, Weill Cornell Medical College, 1165 York Avenue, New York, NY 10065, USA.

Department of Internal Medicine, Division of Endocrinology, Weill Cornell Medical College, 1165 York Avenue, New York, NY 10065, USA.

出版信息

Med Clin North Am. 2021 Jan;105(1):149-174. doi: 10.1016/j.mcna.2020.08.018. Epub 2020 Nov 7.

DOI:10.1016/j.mcna.2020.08.018
PMID:33246516
Abstract

Obesity is a chronic disease caused by dysregulated energy homeostasis pathways that encourage the accumulation of adiposity, which in turn results in the development or exacerbation of weight-related comorbidities. Treatment of obesity relies on a foundation of lifestyle modification; weight loss pharmacotherapy, bariatric surgery and devices are additional tools to help patients achieve their health goals. Appropriate management of patients with obesity provides multiple metabolic benefits beyond weight loss.

摘要

肥胖是一种由能量平衡途径失调引起的慢性疾病,它会促使脂肪堆积,从而导致与体重相关的合并症的发展或恶化。肥胖的治疗依赖于生活方式的改变;减肥药物治疗、减重手术和器械是帮助患者实现健康目标的额外工具。肥胖患者的合理管理除了减轻体重之外,还能带来多种代谢益处。

相似文献

1
Best Practices in the Management of Overweight and Obesity.超重和肥胖管理的最佳实践。
Med Clin North Am. 2021 Jan;105(1):149-174. doi: 10.1016/j.mcna.2020.08.018. Epub 2020 Nov 7.
2
Treatment of overweight and obesity: lifestyle, pharmacologic, and surgical options.超重与肥胖的治疗:生活方式、药物及手术治疗方案
Clin Cornerstone. 2009;9(4):55-68; discussion 69-71. doi: 10.1016/s1098-3597(09)80005-7.
3
Expert Panel Report: Guidelines (2013) for the management of overweight and obesity in adults.专家小组报告:《2013年成人超重和肥胖管理指南》
Obesity (Silver Spring). 2014 Jul;22 Suppl 2:S41-410. doi: 10.1002/oby.20660.
4
Mechanisms, Pathophysiology, and Management of Obesity.肥胖的机制、病理生理学及管理
N Engl J Med. 2017 Jan 19;376(3):254-266. doi: 10.1056/NEJMra1514009.
5
Interventions for treating overweight and obesity in adolescents.青少年超重和肥胖的治疗干预措施。
Adolesc Med State Art Rev. 2012 Dec;23(3):544-70.
6
Overweight and obesity management strategies.超重与肥胖管理策略。
Am J Manag Care. 2016 Jun;22(7 Suppl):s186-96.
7
Prevention of type 2 diabetes; a systematic review and meta-analysis of different intervention strategies.2型糖尿病的预防;不同干预策略的系统评价与荟萃分析
Diabetes Obes Metab. 2014 Aug;16(8):719-27. doi: 10.1111/dom.12270. Epub 2014 Feb 27.
8
Executive summary: Guidelines (2013) for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Obesity Society published by the Obesity Society and American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Based on a systematic review from the The Obesity Expert Panel, 2013.执行摘要:《2013年成人超重与肥胖管理指南》:美国心脏病学会/美国心脏协会实践指南工作组与肥胖协会联合发布的报告,由肥胖协会以及美国心脏病学会/美国心脏协会实践指南工作组出版。基于肥胖专家小组2013年的系统综述。
Obesity (Silver Spring). 2014 Jul;22 Suppl 2:S5-39. doi: 10.1002/oby.20821.
9
A clinician's approach to medical management of obesity.临床医生对肥胖症医学管理的方法。
Am J Med Sci. 2006 Apr;331(4):175-82. doi: 10.1097/00000441-200604000-00003.
10
Reprint: 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults.
J Am Pharm Assoc (2003). 2014 Jan-Feb;54(1):e3. doi: 10.1331/japha.2014.14502.

引用本文的文献

1
White Adipocyte Stem Cell Expansion Through Infant Formula Feeding: New Insights into Epigenetic Programming Explaining the Early Protein Hypothesis of Obesity.通过婴儿配方奶粉喂养实现白色脂肪干细胞扩增:肥胖早期蛋白质假说的表观遗传编程新见解
Int J Mol Sci. 2025 May 8;26(10):4493. doi: 10.3390/ijms26104493.
2
Comparative efficacy and safety of GLP-1 receptor agonists for weight reduction: A model-based meta-analysis of placebo-controlled trials.胰高血糖素样肽-1受体激动剂用于减肥的疗效和安全性比较:基于模型的安慰剂对照试验荟萃分析
Obes Pillars. 2025 Jan 30;13:100162. doi: 10.1016/j.obpill.2025.100162. eCollection 2025 Mar.
3
Safety and effects of anti-obesity medications on weight loss, cardiometabolic, and psychological outcomes in people living with overweight or obesity: a systematic review and meta-analysis.
抗肥胖药物对超重或肥胖人群体重减轻、心脏代谢及心理结局的安全性和效果:一项系统评价与荟萃分析
EClinicalMedicine. 2024 Dec 27;79:103020. doi: 10.1016/j.eclinm.2024.103020. eCollection 2025 Jan.
4
Alterations in Biomarkers Associated with Cardiovascular Health and Obesity with Short-Term Lifestyle Changes in Overweight Women: The Role of Exercise and Diet.超重女性短期生活方式改变与心血管健康和肥胖相关生物标志物的变化:运动和饮食的作用
Medicina (Kaunas). 2024 Dec 7;60(12):2019. doi: 10.3390/medicina60122019.
5
Gut Microbiota-microRNA Interactions and Obesity Pathophysiology: A Systematic Review of Integrated Studies.肠道微生物群- microRNA相互作用与肥胖病理生理学:综合研究的系统评价
Int J Mol Sci. 2024 Nov 29;25(23):12836. doi: 10.3390/ijms252312836.
6
Isokinetic Knee Strengthening Impact on Physical and Functional Performance, Pain Tolerance, and Quality of Life in Overweight/Obese Women with Patellofemoral Pain Syndrome.等速膝关节强化训练对患有髌股疼痛综合征的超重/肥胖女性身体和功能表现、疼痛耐受性及生活质量的影响
J Clin Med. 2024 Aug 10;13(16):4696. doi: 10.3390/jcm13164696.
7
Obesogenic Medication Use in End-Stage Kidney Disease and Association With Transplant Listing.肥胖相关药物在终末期肾病中的应用及其与移植登记的关系。
Clin Transplant. 2024 Aug;38(8):e15414. doi: 10.1111/ctr.15414.
8
Development and validation of a healthy diet and physical activity tool based on health action process approach among patients undergone bariatric surgery.基于健康行动过程方法,为接受减肥手术的患者开发并验证一种健康饮食和身体活动工具。
J Diabetes Metab Disord. 2024 Jan 5;23(1):1007-1015. doi: 10.1007/s40200-023-01380-5. eCollection 2024 Jun.
9
Impact of Obesity on Cardiac Volumes and Left Ventricular Diameter: A Cross-Sectional Study in an Iranian Heart Center.肥胖对心脏容积和左心室直径的影响:伊朗某心脏中心的一项横断面研究。
Adv Med. 2024 Jun 12;2024:7038875. doi: 10.1155/2024/7038875. eCollection 2024.
10
The New Challenge of Obesity - Obesity-Associated Nephropathy.肥胖的新挑战——肥胖相关性肾病
Diabetes Metab Syndr Obes. 2024 May 6;17:1957-1971. doi: 10.2147/DMSO.S433649. eCollection 2024.